Back
MoonLake Immunotherapeutics Stock Predictions
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Buy
77
MLTX
MoonLake Immunotherapeutics
Last Price:
51.00
Seasonality Move:
10.4%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.MoonLake Immunotherapeutics Stock Forecast
- Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 208.6% based on the past 3 years of stock performance.
- MoonLake Immunotherapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is MoonLake Immunotherapeutics Stock Undervalued?
The current MoonLake Immunotherapeutics [MLTX] share price is $50.99. The Score for MLTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal. - MLTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will MoonLake Immunotherapeutics Stock Go Up Next Year?
- Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 208.6% based on the past 3 years of stock performance.
MoonLake Immunotherapeutics Stock Rating
Buy
77
MoonLake Immunotherapeutics (MLTX)
is a Buy
Is MoonLake Immunotherapeutics overpriced?
- MoonLake Immunotherapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
MoonLake Immunotherapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
moonlaketx.com
52-Week Data
52-Week High:
64.98
52-Week Low:
35.11
Prediction Charts
Market Cap:
3.21B
Price in USD:
50.99
Volume:
444.22K
Beta:
1.27
Technical Analysis
SMA50:
46.34
SMA100:
43.90
SMA200:
48.42
52-Wk Change:
-9.3%
Stock Predictions
-
Is MoonLake Immunotherapeutics stock public?
Yes, MoonLake Immunotherapeutics is a publicly traded company. -
What is the MoonLake Immunotherapeutics stock quote today?
The MoonLake Immunotherapeutics stock price is 50.99 USD today. -
How to buy MoonLake Immunotherapeutics stock online?
You can buy MoonLake Immunotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Aug-28 | 47.03 | 46.81 | 47.87 | 46.69 |
| Aug-29 | 46.70 | 47.48 | 47.66 | 46.57 |
| Aug-30 | 47.78 | 46.73 | 47.78 | 46.50 |
| Sep-3 | 46.65 | 46.31 | 48.65 | 45.76 |
| Sep-4 | 46.09 | 47.41 | 48.35 | 45.91 |
| Sep-5 | 47.09 | 45.58 | 47.25 | 45.27 |
| Sep-6 | 45.53 | 46.01 | 46.05 | 44.71 |
| Sep-9 | 46.35 | 46.76 | 47.19 | 46.23 |
| Sep-10 | 46.94 | 46.60 | 47.18 | 45.31 |
| Sep-11 | 46.50 | 46.47 | 46.68 | 45.40 |
| Sep-12 | 47.00 | 50.99 | 51.95 | 46.80 |
| Sep-13 | 51.10 | 51.14 | 52.71 | 50.25 |
| Sep-16 | 51.54 | 49.98 | 51.61 | 49.97 |
| Sep-17 | 49.99 | 50.99 | 51.09 | 47.70 |
MoonLake Immunotherapeutics Earnings
MoonLake Immunotherapeutics Earnings Report: Per Share MoonLake Immunotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
MoonLake Immunotherapeutics Forecast Revenue Growth
MoonLake Immunotherapeutics Stock Analysis: Historical quarterly revenues per share for MoonLake Immunotherapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.20 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.79 per share.
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.